Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy

• Bettina Hoden,
• Yasuhiro Nagai,
• Laura Schuettpelz,
• Dekai Zhang

Affiliations

Bettina Hoden

Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States

Yasuhiro Nagai

Cancer Research Unit, Sumitomo Pharma Co. Ltd., Osaka, Japan

Laura Schuettpelz

Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States

Dekai Zhang

Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States